Measure #176- Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy EZDERM Support L1 January 03, 2025 13:59 Updated Follow Additional Resources: Healthmonix Detailed Measure Description Related articles MACRA # 485 & 486- Psoriasis/Dermatitis Improvement in Patient-Reported Itch Severity Measure #374- Closing the Referral Loop, Receipt of Specialist Report MACRA #487- Screening for Social Drivers of Health MACRA #410- Psoriasis Clinical Response to Systemic Medications Measure #355- Unplanned Reoperation within the 30 Day Postoperative Period Comments 0 comments Please sign in to leave a comment.
Comments
0 comments
Please sign in to leave a comment.